
Oncolytics Biotech ONCY
€ 0.76
0.81%
Geschäftsbericht 2024
hinzugefügt 27.12.2025
Oncolytics Biotech DPO 2011-2025 | ONCY
DPO Jährlich Oncolytics Biotech
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | 549 | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 549 | 549 | 549 |
DPO anderer Aktien in der Pharmaeinzelhändler
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.02 | 4.0 % | $ 233 M | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 1.1 | -1.1 % | $ 6 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 11.79 | 1.64 % | $ 776 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 26.9 | -0.37 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Certara
CERT
|
10.2 | $ 8.82 | -0.4 % | $ 1.41 B | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.59 | 0.42 % | $ 141 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Cellectis S.A.
CLLS
|
975 | $ 4.8 | 0.42 % | $ 116 M | ||
|
Axon Enterprise
AXON
|
29.9 | $ 572.92 | 0.14 % | $ 43.4 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.59 | 1.37 % | $ 16.3 M | ||
|
ChromaDex Corporation
CDXC
|
90.1 | - | -0.88 % | $ 598 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 92.12 | -0.43 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
105 | - | -5.38 % | $ 6.06 M | ||
|
Celldex Therapeutics
CLDX
|
6.17 K | $ 27.38 | 3.58 % | $ 1.76 M | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
199 | $ 11.5 | -1.2 % | $ 744 M |